FDA Inspection 1017293 — Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.

Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. — FEI 3002807242

The FDA completed an inspection of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. on July 4, 2017 in Aprilia. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 4, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aprilia (Italy)

Citations

IDCFRDescription
192221 CFR 211.166(a)(4)Testing in same container - closure system
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
362921 CFR 211.170(b)Reserve samples identified, representative, stored